Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 2,500 | $0.30 | $749.75 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 15 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,849 Read SEC document |
| June 21, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 3,700 | $0.39 | $1,443.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 14 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,349 Read SEC document |
| June 17, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 9,600 | $0.28 | $2,707.20 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 13 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,649 Read SEC document |
| June 16, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 500 | $0.13 | $63.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 12 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,049 Read SEC document |
| June 14, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 500 | $0.18 | $91.05 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 11 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,549 Read SEC document |
| June 06, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 300 | $0.43 | $127.53 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 10 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,049 Read SEC document |
| May 23, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 100 | $0.50 | $50.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 9 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,749 Read SEC document |
| May 17, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 100 | $0.50 | $49.99 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 8 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,649 Read SEC document |
| May 16, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 200 | $0.42 | $83.18 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 7 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,549 Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:08 UTC |
Buttorff LeslieDirector · CEO · 10% owner
|
PurchaseCommon Stock | 1,050 | $0.48 | $507.05 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 5 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,449 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC |
Buttorff LeslieDirector · CEO · 10% owner
|
PurchaseCommon Stock | 1,404 | $0.60 | $842.40 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 4 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,399 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC |
Buttorff LeslieDirector · CEO · 10% owner
|
PurchaseCommon Stock | 4,096 | $0.45 | $1,843.20 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,995 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC |
Buttorff LeslieDirector · CEO · 10% owner
|
PurchaseCommon Stock | 500 | $0.59 | $295.00 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,899 Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC |
Buttorff LeslieDirector · CEO · 10% owner
|
PurchaseCommon Stock | 11,000 | $0.50 | $5,500.00 |
DisclosureSEC source: 0001493152-22-009276 · ownership.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,399 Read SEC document |
| February 16, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 100 | $0.70 | $69.80 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 6 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,349 Read SEC document |
| February 11, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 200 | $0.69 | $137.60 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 5 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,249 Read SEC document |
| January 25, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 700 | $0.85 | $594.93 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 4 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,049 Read SEC document |
| January 20, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 2,300 | $0.66 | $1,506.50 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,349 Read SEC document |
| January 19, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 1,000 | $0.71 | $710.00 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663,049 Read SEC document |
| January 18, 2022 Filed Jan 30, 2023 11:10 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 1,100 | $0.71 | $784.30 |
DisclosureSEC source: 0001493152-23-002844 · ownership.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,049 Read SEC document |
| December 21, 2021 Filed Feb 14, 2022 23:36 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 1,000 | $0.90 | $902.40 |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,399 Read SEC document |
| December 21, 2021 Filed Feb 14, 2022 23:36 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 500 | $1.00 | $499.90 |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,399 Read SEC document |
| October 25, 2021 Filed Feb 14, 2022 23:36 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
GrantSeries C-2 Preferred Stock | 100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 6 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 100 F2 · security: The Series C-2 designates 100 shares for issuance, par value $0.0001 per share. Each share of Series C-2 is convertible into 73,215 shares of the Company's common stock and is entitled to vote on all matters submitted to the Company's stockholders on an as-converted basis. Other than the conversion and voting rights, there are no other preferences. F3 · price: The shares of preferred stock were acquired in connection with the cancellation of 7,321,429 shares of the Company's common stock that were held by Quintel-MC, Incorporated. Read SEC document |
| October 25, 2021 Filed Feb 14, 2022 23:36 UTC |
Buttorff LeslieDirector · Chief Executive Officer · 10% owner
|
Disposition to issuerCommon Stock | 7,321,429 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-22-004599 · ownership.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 4,047,054 F1 · price: The shares of common stock were cancelled in connection with the designation of 100 shares of Series C-2 Convertible Preferred Stock to Quintel-MC, Incorporated. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:16 UTC |
Wert LawrenceDirector
|
GrantStock Options (Right to Buy) · Derivative | 28,000,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003399 · form4-07022021_010704.xml · derivative · entry 1 Wert Lawrence · CIK 0001626623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000,000 Underlying: Common Stock · 28,000,000 shares Expires 2026-06-30 F1 · derivative.exercise_date: One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued service as a director of the Issuer. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC |
Buttorff LeslieDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
GrantSeries D Preferred Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 5 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by J&N Real Estate Company LLC Disclosed balance after: 10,000 F2 · price: The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC |
Buttorff LeslieDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
GrantSeries C-1 Preferred Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 4 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 10,000 F2 · price: The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC |
Buttorff LeslieDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
GrantSeries C Preferred Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 3 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 1,000,000 F2 · price: The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC |
Buttorff LeslieDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
GrantCommon Stock | 318,317,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 2 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Quintel-MC, Incorporated Disclosed balance after: 318,317,499 F1 · price: The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the "Exchange Agreement"). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:05 UTC |
Buttorff LeslieDirector · CHIEF EXECUTIVE OFFICER · 10% owner
|
GrantCommon Stock | 16,797,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003386 · form4-07022021_040701.xml · nonDerivative · entry 1 Buttorff Leslie · CIK 0001866792 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,797,145 F1 · price: The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the "Exchange Agreement"). Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 21:28 UTC |
Berman Nathan JoelCONTROLLER & PRIN ACTNG OFCR
|
GrantStock Options (Right to Buy) · Derivative | 496,957 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003515 · form4-07062021_020722.xml · derivative · entry 2 Berman Nathan Joel · CIK 0001871296 · CONTROLLER & PRIN ACTNG OFCR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,957 Underlying: Common Stock · 496,957 shares Expires 2026-06-30 F2 · derivative.exercise_date: One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued employment with the Issuer. Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 21:28 UTC |
Berman Nathan JoelCONTROLLER & PRIN ACTNG OFCR
|
GrantCommon Stock | 496,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-003515 · form4-07062021_020722.xml · nonDerivative · entry 1 Berman Nathan Joel · CIK 0001871296 · CONTROLLER & PRIN ACTNG OFCR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,957 F1 · price: The shares of common stock of the Issuer were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 by and among the Issuer, Panacea and the shareholders of Panacea. Read SEC document |
| June 30, 2021 Filed Jul 7, 2021 01:56 UTC Amendment |
Wert LawrenceDirector
|
GrantOptions · Derivative | 28,000,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003532 · form4a-07062021_060702.xml · derivative · entry 5 Wert Lawrence · CIK 0001626623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000,000 Underlying: Common Stock · 28,000,000 shares Expires 2026-06-30 F2 · derivative.exercise_date: Shares issued upon exchange of non-qualified incentive options for an equivalent number of shares of common stock. Read SEC document |
| June 30, 2021 Filed Jul 7, 2021 01:56 UTC Amendment |
Wert LawrenceDirector
|
GrantCommon Stock | 28,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003532 · form4a-07062021_060702.xml · nonDerivative · entry 3 Wert Lawrence · CIK 0001626623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,620,297 F3 · security: Consists of options to purchase common stock at a price of $0.10 per share. One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued service as a director of the Issuer. Read SEC document |
| March 31, 2021 Filed Jul 7, 2021 01:56 UTC Amendment |
Wert LawrenceDirector
|
Disposition to issuerOptions · Derivative | 3,500,000 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001415889-21-003532 · form4a-07062021_060702.xml · derivative · entry 4 Wert Lawrence · CIK 0001626623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500,000 shares Expires 2023-01-22 F1 · security: Shares issued as director compensation. Read SEC document |
| March 31, 2021 Filed Jul 7, 2021 01:56 UTC Amendment |
Wert LawrenceDirector
|
GrantCommon Stock | 3,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003532 · form4a-07062021_060702.xml · nonDerivative · entry 2 Wert Lawrence · CIK 0001626623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,620,297 F2 · security: Shares issued upon exchange of non-qualified incentive options for an equivalent number of shares of common stock. Read SEC document |
| March 01, 2021 Filed Jul 7, 2021 01:56 UTC Amendment |
Wert LawrenceDirector
|
GrantCommon Stock | 65,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003532 · form4a-07062021_060702.xml · nonDerivative · entry 1 Wert Lawrence · CIK 0001626623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,620,297 F1 · security: Shares issued as director compensation. Read SEC document |
| January 22, 2021 Filed Feb 2, 2021 18:56 UTC |
Johnson Andrew L.CHIEF GROWTH OFFICER
|
GrantOptions to purchase common stock · Derivative | 3,500,000 | $0.03 Strike: $0.03 | $87,500.00 |
DisclosureSEC source: 0001415889-21-000478 · form4-02022021_100200.xml · derivative · entry 2 Johnson Andrew L. · CIK 0001773143 · CHIEF GROWTH OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500,000 Underlying: Common stock · 3,500,000 shares Expires 2023-01-22 F3 · derivative.exercise_date: The reporting person was granted two year options to purchase 3,500,000 shares of Common Stock at an exercise price of $0.025 per share. Provided Mr. Johnson has not resigned or been removed prior to vesting, fifty (50%) percent of such amount shall vest upon issuance and fifty (50%) percent upon the closing of any acquisition with a combined value (target and the Corporation) in excess of five million ($5,000,000) dollars. Read SEC document |
| January 22, 2021 Filed Feb 2, 2021 18:56 UTC |
Johnson Andrew L.CHIEF GROWTH OFFICER
|
GrantCommon Stock | 8,186,240 | $0.03 | $204,656.00 |
DisclosureSEC source: 0001415889-21-000478 · form4-02022021_100200.xml · nonDerivative · entry 1 Johnson Andrew L. · CIK 0001773143 · CHIEF GROWTH OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,792,490 F1 · price: The reporting person was issued a total of 8,186,240 shares of common stock in payment of accrued compensation, reimbursable expenses, and loans advanced to the company. F2 · balance_after: Consists of 8,498,740 shares of common stock, together with: (i) options to purchase 31,250 shares of common stock at a price of $0.96 per share, exercisable until 1/15/29; (ii) options to purchase 12,500 shares of common stock at a price of $0.32 per share, exercisable until 1/15/29; (iii) options to purchase 750,000 shares of common stock at a price of $0.32 per share, exercisable until 3/12/29; and (iv) options to purchase 3,500,00 shares of common stock at a price of $0.025 per share, exercisable until 1/22/23. Read SEC document |
| January 22, 2021 Filed Feb 2, 2021 18:57 UTC |
Alberttis Alvaro DanielDirector · CHIEF OPERATING OFFICER
|
GrantOptions to purchase common stock · Derivative | 2,500,000 | $0.03 Strike: $0.03 | $62,500.00 |
DisclosureSEC source: 0001415889-21-000480 · form4-02022021_100218.xml · derivative · entry 2 Alberttis Alvaro Daniel · CIK 0001801089 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common stock · 2,500,000 shares Expires 2023-01-22 F3 · derivative.exercise_date: (1) The reporting person was granted two year options to purchase 2,500,000 shares of Common Stock at an exercise price of $0.025 per share. Provided Mr. Alberttis has not resigned or been removed prior to vesting, fifty (50%) percent of such amount shall vest upon his execution of the Corporation's Annual Report on Form 10-K for filing with the SEC for the Corporation's fiscal year ended December 31, 2020 on or prior to the due date thereof, including any and all Certifications thereto required to be executed by Mr. Alberttis under the Sarbanes-Oxley Act of 2002 (as well as any amendments and any other SEC filings or reports as requested) and fifty (50%) percent upon the closing of any acquisition with a combined value (target and the Corporation) in excess of five million ($5,000,000) dollars (the "Acquisition"). (continued, see Footnote 4) F4 · derivative.exercise_date: (cont'd) Upon closing of an Acquisition, all options shall immediately vest if, and only if, a new chief financial and chief executive officer is appointed who will be responsible for filing and certifying the Form 10-K, provided Mr. Alberttis shall also be required to render reasonable assistance in connection therewith upon request. Read SEC document |
| January 22, 2021 Filed Feb 2, 2021 18:57 UTC |
Alberttis Alvaro DanielDirector · CHIEF OPERATING OFFICER
|
GrantCommon stock | 2,039,241 | $0.03 | $50,981.03 |
DisclosureSEC source: 0001415889-21-000480 · form4-02022021_100218.xml · nonDerivative · entry 1 Alberttis Alvaro Daniel · CIK 0001801089 · Director · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,777,337 F1 · price: The reporting person was issued a total of 2,039,241 shares of common stock in payment of accrued compensation. F2 · balance_after: Consists of 2,277,337 shares of common stock, together with options to purchase 2,500,00 shares of common stock at a price of $0.025 per share, exercisable until 1/22/23. Read SEC document |
| February 01, 2020 Filed Feb 6, 2020 20:08 UTC |
Johnson Andrew L.CHIEF STRATEGY OFFICER
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000288 · form4-02062020_120200.xml · nonDerivative · entry 1 Johnson Andrew L. · CIK 0001773143 · CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106,250 F1 · balance_after: Consists of 312,500 shares of common stock, together with: (i) options to purchase 31,250 shares of common stock at a price of $0.96 per share, exercisable until 1/15/29; (ii) options to purchase 12,500 shares of common stock at a price of $0.32 per share, exercisable until 1/15/29; and (iii) options to purchase 750,000 shares of common stock at a price of $0.32 per share, exercisable until 3/12/29 Read SEC document |
| February 01, 2020 Filed Feb 6, 2020 20:07 UTC |
Puzder KenDirector · CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000287 · form4-02062020_120208.xml · nonDerivative · entry 1 Puzder Ken · CIK 0001764453 · Director · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F1 · balance_after: Consists of 250,000 shares of common stock as reported herein, together with options to purchase 250,000 shares of common stock at a price of $0.20 per share, exercisable until 1/11/29 Read SEC document |
| December 18, 2019 Filed Dec 19, 2019 21:37 UTC |
Johnson Andrew L.CHIEF STRATEGY OFFICER
|
PurchaseCommon Stock | 62,500 | $0.40 | $25,000.00 |
DisclosureSEC source: 0001415889-19-001542 · form4-12192019_011208.xml · nonDerivative · entry 1 Johnson Andrew L. · CIK 0001773143 · CHIEF STRATEGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856,250 F1 · balance_after: Consists of 62,500 shares of common stock as reported herein, together with: (i) options to purchase 31,250 shares shares of common stock at a price of $0.96 per share, exercisable until 1/15/29; (ii) options to purchase 12,500 shares of common stock at a price of $0.32 per share, exercisable until 1/15/29; and (iii) options to purchase 750,000 shares of common stock at a price of $0.32 per share, exercisable until 3/12/29 Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 22:39 UTC |
Ceed2Med LLCDirector · 10% owner
Yampolsky VladislavDirector · 10% owner
|
OtherCommon Stock, Par Value $0.0001 per Share | 1,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001504 · form4-12132019_021251.xml · nonDerivative · entry 1 Ceed2Med LLC · CIK 0001764452 · Director · 10% owner Yampolsky Vladislav · CIK 0001782054 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,435,691 F1 · shares: Represents shares of common stock of Exactus, Inc. (the "Issuer"), par value $0.0001 per share ("Shares"), that were distributed by Ceed2Med, LLC ("C2M") to one of its non-managing members in connection with its internal operational purposes. F2 · ownership.direct: This statement is jointly filed by and on behalf of each of C2M and Mr. Vladislav Yampolsky (the "Reporting Persons"). Mr. Yampolsky is the Managing Member of C2M. As such, Mr. Yampolsky may be deemed to beneficially own securities owned by C2M. F3 · ownership.direct: The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities. F4 · ownership.direct: Represents Shares directly beneficially owned by C2M. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 18:00 UTC |
ESVAL KEVIN JAMESDirector
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001388 · form4-11222019_031136.xml · nonDerivative · entry 1 ESVAL KEVIN JAMES · CIK 0001438014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,250 F1 · shares: Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director. F2 · balance_after: Reflects adjustment for the 1:8 reverse split of common stock, effective February 25, 2019. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 23:03 UTC |
Thompson Jeffrey MDirector
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001389 · form4-11222019_031118.xml · nonDerivative · entry 1 Thompson Jeffrey M · CIK 0001397565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · shares: Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 23:04 UTC |
Price John CDirector
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001390 · form4-11222019_031127.xml · nonDerivative · entry 1 Price John C · CIK 0001636242 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · shares: Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director. Read SEC document |
| September 13, 2019 Filed Oct 4, 2019 19:03 UTC |
Yampolsky VladislavDirector · 10% owner
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001153 · form4-10042019_121033.xml · nonDerivative · entry 1 Yampolsky Vladislav · CIK 0001782054 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: Award of restricted common stock that vests equally over 48 months commencing October 1, 2019. Read SEC document |
| September 13, 2019 Filed Oct 7, 2019 16:47 UTC |
Aloi Emiliano AngelPRESIDENT AND INTERIM CEO
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001156 · form4-10072019_091000.xml · nonDerivative · entry 1 Aloi Emiliano Angel · CIK 0001774524 · PRESIDENT AND INTERIM CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: Award of shares of restricted common stock that commence vesting upon the satisfaction of certain performance conditions, after which the shares shall vest equally over 48 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.